Manus Neurodynamica, which develops and markets products and technologies for neuromotor assessment, has closed a £2.6 million funding round to support the commercialisation of its NeuroMotor Pen – a medical device to aid diagnosis and monitoring of neuromotor disorders including Parkinson’s disease.
Existing investors supported the £2.6 million investment round including the North East Innovation Fund, supported by the European Regional Development Fund, and managed by Northstar Ventures co-leading the round with Par Equity with participation from SIS Ventures, Scottish Enterprise and Old College Capital.
Read more HERE.
